News
DNA diagnostics market to reach $24.7b by 2034 on precision medicine, genomic advancements
DNA diagnostics market to reach $24.7b by 2034 on precision medicine, genomic advancements
Asia-Pacific emerges as a key growth region.
23 hours ago
Melbourne's Angliss Hospital set to open $78m expansion
Four operating theatres and a 32-bed ward increase capacity for surgery and inpatient care.
1 day ago
Boustead buys 60% of UroMedTech in $6m prostate cancer bet
The $6m investment expands the group's healthcare portfolio.
1 day ago
India rolls out terminology, drug registry
The terminology service will be set up for consistent interpretation and exchange of health data.
1 day ago
Asia-Pacific nations roll out WHO framework on air, health risks
Eleven governments launched WHO-backed efforts to strengthen health-based policymaking.
1 day ago
AI-powered microscopy software poised for $3.09b surge by 2031
North America accounted for the largest market share in 2025.
1 day ago
Healthway Medical expands with Bridgepoint Health buy
It will add 16 clinics and lift annual patient capacity above 1.3 million visits.
1 day ago
Abu Dhabi and MIT Koch advance AI-driven cancer research
It includes physician-scientist fellowships.
1 day ago
Biomarkers market to top $112b by 2031 on drug discovery demand
Consumables held the largest share at 73.4% in 2025.
1 day ago
AU’s Royal North Shore expands cancer trials access with new unit
It was funded by a $13.8m (AU$20m) gift.
2 days ago
Taiwan's NTUH, EVA Air launch in-flight doctor programme
Physicians recommend scheduling a consultation four to six weeks before departure.
2 days ago
Singapore's CGH cuts desflurane, slashes emissions
Desflurane usage fell to just 1.44 litres in 2025 from 242 litres in 2019.
2 days ago
Seoul St. Mary's Hospital, Dankook University centres team up on health tech prototypes
They will reduce prototyping time and costs.
2 days ago
Indonesia anchors Longevity 5.0 amidst regional stem cell gaps
Borderless Healthcare links regenerative medicine with clinics, resorts, and home-based wellness.
4 days ago
RESILIA valves reshape lifetime care planning
Durability data and transcatheter reintervention options are influencing treatment decisions across Asia-Pacific
4 days ago
Tissue valve uptake hinges on data and diagnosis
Durability evidence is shifting younger patient use whilst awareness remains Australia’s main adoption barrier.
4 days ago
RESILIA data widens tissue valve options for younger patients
Awareness and price still slow adoption as durability evidence challenges mechanical valve trade-offs.
4 days ago
Most Read
1. Healthway Medical expands with Bridgepoint Health buy 2. AI drug discovery, GLP-1, and the next wave of Hong Kong biotech listings 3. China's healthcare sector set for global breakout 4. How can healthcare providers make AI pay off? 5. IHH Healthcare, MMA, and Monash University Malaysia partner to strengthen GP-specialist careResource Center
Read Here
Advertise
Sign Up
Partner Events
Event News
Demand was strong for AI-driven and digital healthcare solutions.
Commentary
AI drug discovery, GLP-1, and the next wave of Hong Kong biotech listings
Beyond symptom control: Redefining IMID care in Malaysia
How decentralised clinical trials can unlock Asia's research potential